Nebivolol Cf

Nebivolol, the active ingredient in Nebivolol Cf, is a beta blocker presented as an oral tablet for oral use. It is used to lower high blood pressure in adult patients.

GNH USA supplies Nebivolol Cf as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nebivolol is a selective β1‑adrenergic antagonist used in the management of elevated blood pressure and related cardiovascular conditions. - Hypertension: lowers systolic and diastolic blood pressure in adults. - Isolated systolic hypertension: reduces elevated systolic pressure while preserving diastolic values. - Essential hypertension: improves vascular tone and overall blood pressure control.

Nebivolol may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Headache: mild to moderate pain in the head. - Dizziness: sensation of light‑headedness, especially on standing. - Fatigue: general tiredness or lack of energy. - Nasal congestion: blocked or runny nose. - Bradycardia: slower than normal heart rate. - Nausea: feeling of stomach upset.

Serious or Rare Side Effects: - Severe bradycardia: markedly low heart rate requiring medical attention. - Symptomatic hypotension: significant drop in blood pressure causing faintness. - Atrioventricular block: impaired electrical conduction in the heart. - Bronchospasm: narrowing of airways, especially in patients with asthma. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Heart failure exacerbation: worsening of existing cardiac insufficiency.

Before initiating therapy, consider the following safety measures. - Cardiovascular assessment: monitor heart rate and blood pressure regularly. - Renal impairment: evaluate kidney function and adjust therapy if needed. - Hepatic disease: use with caution in patients with liver dysfunction. - Concomitant beta‑blockers: avoid duplicate therapy to prevent excessive β‑blockade. - Pregnancy: safety not established; weigh risks and benefits. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture.

Nebivolol can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Other beta‑blockers: additive β‑blockade may cause severe bradycardia. - Calcium‑channel blockers (verapamil, diltiazem): increase risk of heart block and low heart rate. - Clonidine: abrupt discontinuation can cause rebound hypertension.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: monitor for excessive hypotension. - Diuretics: watch for electrolyte disturbances and volume depletion. - SSRIs or other antidepressants: may affect heart rate and blood pressure control.